Forum 1: Innovative Antibody & Protein Therapeutics R&D Apr. 22-23
Co planner
Innovative Target and Therapy Development Driven by Translational Science/Basic Research Innovative Development/Engineering of Bispecific Antibody, Polyclonal Antibody & Fusion Protein and Translational Medicine
Innovative Development and Translational Medicine/Clinical Development of Bispecific/Polyclonal Antibody Innovative Development and Translational Science of ADC
Forum 2: Antibody & Protein Bioprocessing Apr. 22-23
Co planner
Upstream Continuous/Automated Process Development and Optimization Downstream Process Development and Analysis of Bispecific Antibody/ADC
Commercialization and Leading Practice of PVPC Leading Practice of Process Amplification and Process Change
Forum 3: Cell Therapy CMC & Industrialization Apr. 22-23
Co planner
Towards Industrialization: GMP Manufacturing and Compliance Towards Industrialization: Quality Control
Low-cost Process Development, Optimization and Modification of Cell Therapy CMC and Process Development of Novel Cell Therapy Products
Forum 4: Oncolytic Virus & Viral Biotherapeutics Apr. 22-23
Co planner
CMC and Process Development of Gene Therapy CMC and Process Development of Oncolytic Virus
Innovative Preclinical Design and Clinical Progress of Oncolytic Virus
Forum 5: Advanced Biomanufacturing Apr. 22-23
Co planner
Excellent Manufacturing & Operation-Reducing Costs and Boosting Efficiency Commercialized Manufacturing Verification and Risk Control Practices
Commercialized Manufacturing Verification and Risk Control Practices Establishment and Application of Future 4.0 Factory
Forum 6: mRNA Vaccine & Therapeutics Apr. 23
Co planner
mRNA Molecular Structure mRNA Delivery Technology
Quality Control of mRNA Drugs Pre-clinical and Clinical Research for mRNA Drugs
Forum 7: China Biopharma Industry Summit Apr. 22
Global Supply Chain and Collaboration
Commercialization: Tackle the Challenges of Market Entry
How to Initiate Projects, Stick to Regulations and Develop Business in the Post-Pandemic Era